Skip to main content
Clinical Trials/NCT00698633
NCT00698633
Terminated
Not Applicable

M2a- Taper™ Hip System Prospective Data Collection

Biomet Orthopedics, LLC0 sites43 target enrollmentDecember 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non-inflammatory Degenerative Joint Disease
Sponsor
Biomet Orthopedics, LLC
Enrollment
43
Primary Endpoint
Harris Hip Score
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this prospective clinical data collection is to document the performance and clinical outcomes of the M2a- Taper™ Hip System

Registry
clinicaltrials.gov
Start Date
December 2001
End Date
December 2008
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients having primary cemented or cementless total hip replacement for non-inflammatory degenerative joint disease (NIDJD), or any of its composite diagnoses of:
  • Osteoarthritis,
  • Avascular Necrosis,
  • Traumatic arthritis,
  • Subcapital fracture,
  • Legg Perthes,
  • Slipped Capital Epiphysis,
  • Fracture of the pelvis,
  • Diastrophic Variant
  • Patients with full skeletal maturity.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Harris Hip Score

Time Frame: Postop, 12 weeks, 1 year, 3 years, 5 years

Secondary Outcomes

  • Incidence of revisions and removals(Any time)

Similar Trials